Optimizing Subsequent CARdiovascular Medication Reintroduction in the Intensive Care Unit.

Hadjer DahelNajla TabbaraLisa BurryGabrielle HornsteinDavid WilliamsonHan Ting Wang

Published in: Canadian journal of kidney health and disease (2024)

Our study uncovered that cardiovascular medication discontinuation for ICU patients is frequent, especially for renin-angiotensin system (RAS) blockers. Data from our study could be used to reinforce site-specific protocols of medication reconciliation and optimization, as well as inform future protocols aimed at RAS blocker reinitiation follow-up.

Keyphrases

healthcare
end stage renal disease
intensive care unit
ejection fraction
newly diagnosed
adverse drug
chronic kidney disease
peritoneal dialysis
big data
wild type
electronic health record
patient reported outcomes